Production (Stage)
AEON Biopharma, Inc.
AEON
$0.534
-$0.015-2.73%
AMEX
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 10.45M | 13.00K | 537.00K | 3.44M | 1.56M |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 1.88M | 1.58M | 1.83M | 577.00K | 940.00K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 12.32M | 1.59M | 2.37M | 4.02M | 2.50M |
|
|
|||||
| Total Current Assets | 12.32M | 1.59M | 2.37M | 4.02M | 2.50M |
| Net Property, Plant & Equipment | 1.45M | 1.52M | 1.60M | 1.69M | 505.00K |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 29.00K | 29.00K | 29.00K | 29.00K | 29.00K |
| Total Assets | 13.80M | 3.14M | 4.00M | 5.73M | 3.03M |
|
|
|||||
| Total Accounts Payable | 2.44M | 5.91M | 4.63M | 3.03M | 6.52M |
| Total Accrued Expenses | 6.01M | 8.12M | 5.97M | 7.27M | 6.23M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 197.00K | 121.00K | 128.00K | 134.00K | 205.00K |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | 3.00M |
| Total Other Current Liabilities | -- | -- | -- | -- | 3.00M |
| Total Current Liabilities | 8.64M | 14.15M | 10.73M | 10.43M | 15.96M |
|
|
|||||
| Total Current Liabilities | 8.64M | 14.15M | 10.73M | 10.43M | 15.96M |
| Long-Term Debt | 13.32M | 11.69M | 15.17M | 13.29M | 5.09M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 1.08M | 1.15M | 1.20M | 1.26M | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 2.08M | 4.73M | 8.99M | 8.70M | 180.37M |
| Total Liabilities | 25.12M | 31.71M | 36.09M | 33.68M | 201.41M |
|
|
|||||
| Common Stock & APIC | 411.18M | 403.03M | 401.59M | 399.56M | 393.24M |
| Retained Earnings | -422.50M | -431.60M | -433.68M | -427.51M | -591.62M |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | -11.32M | -28.57M | -32.09M | -27.95M | -198.38M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -11.32M | -28.57M | -32.09M | -27.95M | -198.38M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -11.32M | -28.57M | -32.09M | -27.95M | -198.38M |
|
|
|||||